FindTrial
Sign In

Lingnan cohort of central nervous system vasculitis (CNSV-Lingnan)

Lingnan cohort of central nervous system vasculitis (CNSV-Lingnan)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108929
Enrollment
Unknown
Registered
2025-09-09
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

central nervous system vasculitis

Interventions

Observation Group:None

Sponsors

The Third Affiliated Hospital Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Cases clinically suspected of central nervous system vasculitis; 2.Prospectively enrolled cases sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Central nervous system vasculitis secondary to CNS infections; 2.Central nervous system vasculitis induced by medications (e.g., methimazole); 3.Cerebral ischemic lesions due to cardioembolism or paradoxical embolism; 4.Hereditary cerebrovascular diseases (e.g., retinal vasculopathy with cerebral leukoencephalopathy); 5.Intravascular lymphoma; 6.Central nervous system demyelinating diseases associated with diffusion restriction on imaging (e.g., multiple sclerosis, neuromyelitis optica, MOG-associated disorders); 7.Patients who refuse to provide informed consent or are deemed ineligible for enrollment by investigators.

Design outcomes

Primary

MeasureTime frame
Annualized relapse rate, ARR;—

Countries

China

Contacts

Public ContactLu Tingting

The Third Affiliated Hospital of Sun Yat-sen University

lutingt@mail.sysu.edu.cn+86 20 85252327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026